S. Baranwal, K. Dey, T. Ramamurthy, G. Nair, and M. Kundu, Role of Active Efflux in Association with Target Gene Mutations in Fluoroquinolone Resistance in Clinical Isolates of Vibrio cholerae, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, pp.2676-2684, 2002.
DOI : 10.1128/AAC.46.8.2676-2678.2002

A. Goel and S. Jiang, Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India, Infection, Genetics and Evolution, vol.10, issue.6, pp.815-824, 2010.
DOI : 10.1016/j.meegid.2009.06.022

A. Safa, J. Sultana, P. Cam, J. Mwansa, and R. Kong, O1 Hybrid El Tor Strains, Asia and Africa, Emerging Infectious Diseases, vol.14, issue.6, pp.987-995, 2008.
DOI : 10.3201/eid1406.080129
URL : http://doi.org/10.3201/eid1406.080129

A. Safa, G. Nair, and R. Kong, Evolution of new variants of Vibrio cholerae O1, Trends in Microbiology, vol.18, issue.1, pp.46-54, 2010.
DOI : 10.1016/j.tim.2009.10.003

P. Garg, S. Chakraborty, I. Basu, S. Datta, K. Rajendran et al., Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992???7 in Calcutta, India, Epidemiology and Infection, vol.124, issue.3, pp.393-402, 2000.
DOI : 10.1017/S0950268899003957

B. Krishna, A. Patil, and M. Chandrasekhar, Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100, issue.3, pp.224-230, 2006.
DOI : 10.1016/j.trstmh.2005.07.007

M. Islam, S. Midzi, L. Charimari, A. Cravioto, and H. Endtz, Susceptibility to Fluoroquinolones of <emph type="ital">Vibrio cholerae</emph> O1 Isolated From Diarrheal Patients in Zimbabwe, JAMA, vol.302, issue.21, pp.2321-2323, 2009.
DOI : 10.1001/jama.2009.1750

. Address, M. David, and . Olson, Doctors Without Borders/Médecins Sans Frontières

N. York, USA; email: david.olson@ newyork.msf.org Emerging Infectious Diseases ? www.cdc.gov/eid ?, 2010.